Presentation of SIINFEKL from HSP/OVA-BiP but not HSP/BiP-OVA is dependent on proteasomal proteases and TAP. (A) The effect of 25 μM lactacystin on the presentation of the indicated antigens to either the B3Z or the 3A9 T cell hybridoma cells was assayed. In bars 1–7, the presentation to B3Z hybridoma cells was analyzed in 1 the absence of any antigen, 2 the presence of 1 nM SIINFEKL peptide, 3 10 nM SIINFEKL peptide, 4 20 nM OVA-BiP, 5 2 μg HSP70/OVA-BiP, 6 20 nM BiP-OVA, or 7 2 μg HSP 70/BiP-OVA complexes. In four independent experiments, the presentation of HSP 70/BiP-OVA was not affected by lactacystin, whereas the inhibition of the presentation of HSP70/OVA-BiP ranged between 70 and 90%. The effect of lactacystin on the presentation of HEL-46-61 to 3A9 hybridoma cells was tested 8 in the absence of any antigen, or 9 in the presence of 1 mg/ml hen egg lysosyme. (B) 105 TAP-1−/− macrophages (C57BL/6 × 129) were grown at 26°C for 24 h and transferred to 37°C when incubation with the indicated antigens and the T cells was started. The presentation to B3Z hybridoma cells was analyzed in 1 the absence of any antigen, 2 the presence of 1 nM SIINFEKL peptide, 3 10 nM SIINFEKL peptide, 4 20 nM OVA-BiP, 5 2 μg HSP70/OVA-BiP, 6 20 nM BiP-OVA, or 7 2 μg HSP 70/BiP-OVA complexes. Similar results were obtained in three independent experiments.